Today's Date: September 26, 2023
"KPMG's Report Highlighting Bitcoin's Positive ESG Contributions Boosts Crypto Perception": PayBito CEO Raj Chowdhury   •   Nippon Sanso Holdings Corporation: Publication of “Integrated Report 2023”   •   Global Superstar Ellie Goulding Visits Zaatari Refugee Camp In Jordan For The Grand Opening Of The Zaatari Music & Arts Cent   •   Immersive Labs Unveils Enterprise-Class Cyber Skills and Resilience Platform for the Entire Organization   •   LyondellBasell Demonstrates Commitment to Sustainability with Launch of +LC (Low Carbon) Solutions   •   Global Times: Foreign reporters accomplish media trip in Xinjiang, impressed with vibrant local economy, diverse culture   •   Fosun International has been awarded the "ESG Benchmark Awards"   •   Worldly Appoints Francois Thrower as New CFO   •   IFCO achieves Cradle to Cradle Certified® Silver recertification for the European Lift Lock RPCs   •   Fosun International's FTSE Russell ESG Rating Upgraded to 3.8, Maintains Inclusion in FTSE4Good Index Series   •   Deloitte Analysis: Employed Women Have as Much as $15.4 Billion More in Out-of-Pocket Medical Expenses a Year Than Men   •   LONGi strives for energy equity to illuminate every child's future with sunshine   •   IQVIA Appoints Richard Staub III President of Research & Development Solutions   •   Priority Financial Group Announces Partnership with the Financial Planning Association of Greater Phoenix   •   WM Sets Date for Third Quarter Earnings Release Conference Call   •   PUMA Welcomes Indian Sustainable Fashion Advocate Aishwarya Sharma To Its Voices Of A RE:GENERATION Initiative   •   RXO Presents the Carolina Panthers Oorah Hooah Classic 7-on-7 Football Tournament   •   University of Phoenix Registered Nurse to Bachelor of Science in Nursing Competency-based Program Helps Advance Skills Amidst Nu   •   HIVENTURES INVESTS IN HUNGARIAN STARTUP THAT CREATES A FUTURE WITHOUT BARRIERS   •   bebe stores, inc. Announces B. Riley’s Agreement to Purchase 3.7M bebe shares from Founder Manny Mashouf
Bookmark and Share

Blacks Benefiting From Targeted Cancer Therapy

 PHILDALPHIA — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

“This study has immediate implications for patient management. Patients with EGFR mutations have a much better prognosis and respond better to erlotinib than those who do not,” said Ramsi Haddad, Ph.D., director of the Laboratory of Translational Oncogenomics at the Barbara Ann Karmanos Cancer Institute, and assistant professor at Wayne State University School of Medicine.

Haddad’s study, which he presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, also showed that African-Americans were more likely to have mutations on exon 19, rather than exon 21, which suggests they would be even more responsive to erlotinib.

Erlotinib, currently marketed as Tarceva by Genentech, has shown remarkable benefits in non-small cell lung cancer patients with EGFR mutations. Other therapies are in development and the genetic testing is clinically available.

Previous studies had suggested that African-Americans had lower rates of EGFR mutation, which researchers had offered as a possible explanation for their generally poorer prognosis.

However, Haddad’s study was larger than previous reports. His research team observed 149 patients with non-small cell lung cancer (NSCLC), including 80 Caucasians and 69 African-Americans.

Using state-of-the-art technology that allowed for simultaneous detection of hundreds of oncogene mutations in clinical samples, they identified EGFR mutations in 20 of these patients, including 12 Caucasians and eight African-Americans. The difference was not statistically significant.

Moreover, 100 percent of the EGFR mutations in African-Americans were in exon 19, compared with only two-thirds of the mutations found in Caucasian patients. 

“It is well-documented that the incidence of lung cancer is higher among African-Americans, particularly men, and that their survival is generally poorer compared to their white counterparts,” said Haddad. “Our data suggest that African-Americans with NSCLC harbor mutations in EGFR at rates similar to whites. Thus, African ancestry should not be a factor when deciding whether to test a tumor for these mutations, as doing so could widen the disparity seen in survival. Physicians treating these patients may want to consider this new information in their treatment decisions.” 

 


STORY TAGS: BLACK , AFRICAN AMERICAN , MINORITY , CIVIL RIGHTS , DISCRIMINATION , RACISM , NAACP , URBAN LEAGUE , RACIAL EQUALITY , BIAS , EQUALITY

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News